Andreas Gille, Ph.D.
Affiliations: | 2003 | University of Kansas, Lawrence, KS, United States |
Area:
Pharmacology, Biochemistry, Molecular BiologyGoogle:
"Andreas Gille"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Roland Seifert | grad student | 2003 | University of Kansas | |
| (Molecular analysis of G(s)-proteins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schmaier AH, Cicardi M, Reshef A, et al. (2017) Abstracts from the 10th C1-inhibitor deficiency workshop Allergy, Asthma & Clinical Immunology. 13: 1-36 |
| Easton R, Gille A, D'Andrea D, et al. (2014) A multiple ascending dose study of CSL112, an infused formulation of ApoA-I. Journal of Clinical Pharmacology. 54: 301-10 |
| Hanson J, Gille A, Offermanns S. (2012) Role of HCAâ‚‚ (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin. Pharmacology & Therapeutics. 136: 1-7 |
| Seifert R, Lushington GH, Mou TC, et al. (2012) Inhibitors of membranous adenylyl cyclases. Trends in Pharmacological Sciences. 33: 64-78 |
| Pinto C, Lushington GH, Richter M, et al. (2011) Structure-activity relationships for the interactions of 2'- and 3'-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases. Biochemical Pharmacology. 82: 358-70 |
| Hübner M, Dixit A, Mou TC, et al. (2011) Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate. Molecular Pharmacology. 80: 87-96 |
| Hanson J, Gille A, Zwykiel S, et al. (2010) Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. The Journal of Clinical Investigation. 120: 2910-9 |
| Suryanarayana S, Göttle M, Hübner M, et al. (2009) Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates. The Journal of Pharmacology and Experimental Therapeutics. 330: 687-95 |
| Pinto C, Hübner M, Gille A, et al. (2009) Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs. Biochemical Pharmacology. 78: 62-9 |
| Göttle M, Geduhn J, König B, et al. (2009) Characterization of mouse heart adenylyl cyclase. The Journal of Pharmacology and Experimental Therapeutics. 329: 1156-65 |